Authors:
HANKS G
HANLON A
PINOVER W
HUNT M
MOVSAS B
SCHULTHEISS T
Citation: G. Hanks et al., DOSE-ESCALATION WITH 3-D CRT IN PROSTATE-CANCER - 5-YEAR DOSE RESPONSES ADN OPTIMAL TREATMENT, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 192-192
Authors:
KALSI S
PROISE M
SCHULTHEISS T
DAWKINS B
HERD K
Citation: S. Kalsi et al., IRON-CORE SUPERCONDUCTING MAGNET DESIGN AND TEST-RESULTS FOR MAGLEV APPLICATION, IEEE transactions on applied superconductivity, 5(2), 1995, pp. 964-967
Authors:
AHMAD NR
LANCIANO RM
CORN BW
SCHULTHEISS T
Citation: Nr. Ahmad et al., POSTOPERATIVE RADIATION-THERAPY FOR SURGICALLY STAGED ENDOMETRIAL CANCER - IMPACT OF TIME FACTORS (OVERALL TREATMENT TIME AND SURGERY-TO-RADIATION INTERVAL) ON OUTCOME, International journal of radiation oncology, biology, physics, 33(4), 1995, pp. 837-842
Citation: Bw. Corn et al., DO THE CURRENT SUBCLASSIFICATIONS OF STAGE T3 ADENOCARCINOMA OF THE PROSTATE HAVE CLINICAL RELEVANCE, Urology, 45(3), 1995, pp. 484-489
Authors:
SCHULTHEISS T
SOMMERGRUBER W
KUSOV Y
GAUSSMULLER V
Citation: T. Schultheiss et al., CLEAVAGE SPECIFICITY OF PURIFIED RECOMBINANT HEPATITIS-A VIRUS 3C PROTEINASE ON NATURAL SUBSTRATES, Journal of virology, 69(3), 1995, pp. 1727-1733
Authors:
CORN BW
HANKS GE
LEE WR
BONIN SR
HUDES G
SCHULTHEISS T
Citation: Bw. Corn et al., PROSTATE-SPECIFIC ANTIGEN DENSITY IS NOT AN INDEPENDENT PREDICTOR OF RESPONSE FOR PROSTATE-CANCER TREATED BY CONFORMAL RADIOTHERAPY, The Journal of urology, 153(6), 1995, pp. 1855-1859
Authors:
SCHULTHEISS T
EMERSON SU
PURCELL RH
GAUSSMULLER V
Citation: T. Schultheiss et al., POLYPROTEIN PROCESSING IN ECHOVIRUS-22 - A FIRST ASSESSMENT, Biochemical and biophysical research communications, 217(3), 1995, pp. 1120-1127
Authors:
LIN ZX
LU MH
SCHULTHEISS T
CHOI J
HOLTZER S
DILULLO C
FISCHMAN DA
HOLTZER H
Citation: Zx. Lin et al., SEQUENTIAL APPEARANCE OF MUSCLE-SPECIFIC PROTEINS IN MYOBLASTS AS A FUNCTION OF TIME AFTER CELL-DIVISION - EVIDENCE FOR A CONSERVED MYOBLAST DIFFERENTIATION PROGRAM IN SKELETAL-MUSCLE, Cell motility and the cytoskeleton, 29(1), 1994, pp. 1-19
Citation: T. Schultheiss et al., TRACKING DOWN THE SITE OF THE HEPATITIS-A VIRUS PRIMARY CLEAVAGE WITHA RECOMBINANT 3C PROTEINASE, Journal of cellular biochemistry, 1994, pp. 173-173
Authors:
LANCIANO R
CORN B
MARTIN E
SCHULTHEISS T
HOGAN WM
ROSENBLUM N
Citation: R. Lanciano et al., PERIOPERATIVE MORBIDITY OF INTRACAVITARY GYNECOLOGIC BRACHYTHERAPY, International journal of radiation oncology, biology, physics, 29(5), 1994, pp. 969-974
Citation: T. Schultheiss et al., PROTEINASE 3C OF HEPATITIS A VIRUS (HAV) CLEAVES THE HAV POLYPROTEIN P2-P3 AT ALL SITES INCLUDING VP1 2A AND 2A/2B/, Virology, 198(1), 1994, pp. 275-281
Authors:
HANKS GE
HANLON A
SCHULTHEISS T
CORN B
SHIPLEY WU
LEE WR
Citation: Ge. Hanks et al., EARLY PROSTATE-CANCER - THE NATIONAL RESULTS OF RADIATION TREATMENT FROM THE PATTERNS OF CARE AND RADIATION-THERAPY ONCOLOGY GROUP STUDIES WITH PROSPECTS FOR IMPROVEMENT WITH CONFORMAL RADIATION AND ADJUVANT ANDROGEN DEPRIVATION, The Journal of urology, 152(5), 1994, pp. 1775-1780
Authors:
LANCIANO R
CORN B
MARTIN E
SCHULTHEISS T
HOGAN DWM
ROSENBLUM N
Citation: R. Lanciano et al., MANAGEMENT OF PERIOPERATIVE MORBIDITY FOR INTRACAVITARY GYNECOLOGIC BRACHYTHERAPY, International journal of radiation oncology, biology, physics, 27, 1993, pp. 200-200